Prevalence of Venous Thromboembolism in Critically Ill Patients with COVID-19

Overview

Journal Br J Haematol

Specialty Hematology

Date 2020 Jun 3

PMID 32484907

Citations 48

Authors

Joseph A Hippensteel

Ellen L Burnham

Sarah E Jolley

Affiliations

Soon will be listed here.

Citing Articles

COVID-19 Increases the Risk of New Myocardial Infarction in Patients with Old Myocardial Infarction: A Retrospective Observational Study.

El-Menyar A, Ramzee A, Asim M, Shahid F, Ata Y, El Baba H Clin Med Insights Cardiol. 2024; 18:11795468241301133.

PMID: 39697349 PMC: 11653445. DOI: 10.1177/11795468241301133.

Clinical characteristics and outcomes of venous thromboembolism in patients hospitalized for COVID-19: Systematic review and meta-analysis.

Henrina J, Putra I, Cahyadi I, Lawrensia S, Hadi Gunawan H, Cahyadi A Thromb Update. 2024; 2:100037.

PMID: 38620815 PMC: 7857988. DOI: 10.1016/j.tru.2021.100037.

Biomarkers of thromboinflammation correlate to COVID-19 infection and admission status in emergency department patients.

Goswami J, MacArthur T, Sridharan M, Tange J, Kirmse A, Lundell K Thromb Update. 2024; 5:100090.

PMID: 38620680 PMC: 8603399. DOI: 10.1016/j.tru.2021.100090.

Systematic testing for venous thromboembolism in hospitalized patients with COVID-19 and raised D-dimer levels.

Weinberg I, Fernandez-Capitan C, Quintana-Diaz M, Demelo-Rodriguez P, Garcia de Casasola G, Fidalgo A Thromb Update. 2024; 2:100029.

PMID: 38620598 PMC: 7832524. DOI: 10.1016/j.tru.2020.100029.

Effects of inflammation on thrombosis and outcomes in COVID-19: secondary analysis of the ATTACC/ACTIV-4a trial.

Walborn A, Heath A, Neal M, Zarychanski R, Kornblith L, Hunt B Res Pract Thromb Haemost. 2023; 7(7):102203.

PMID: 37854455 PMC: 10579532. DOI: 10.1016/j.rpth.2023.102203.

References

Cheng Y, Liu Z, Yao F, Zeng W, Zheng D, Dong Y . Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. PLoS Med. 2013; 10(9):e1001515. PMC: 3775725. DOI: 10.1371/journal.pmed.1001515. View

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

Klok F, Kruip M, van der Meer N, Arbous M, Gommers D, Kant K . Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res. 2020; 191:148-150. PMC: 7192101. DOI: 10.1016/j.thromres.2020.04.041. View

Connors J, Levy J . COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020; 135(23):2033-2040. PMC: 7273827. DOI: 10.1182/blood.2020006000. View

Wichmann D, Sperhake J, Lutgehetmann M, Steurer S, Edler C, Heinemann A . Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020; 173(4):268-277. PMC: 7240772. DOI: 10.7326/M20-2003. View

Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T . Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020; 191:9-14. PMC: 7177070. DOI: 10.1016/j.thromres.2020.04.024. View

Middeldorp S, Coppens M, van Haaps T, Foppen M, Vlaar A, Muller M . Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020; 18(8):1995-2002. PMC: 7497052. DOI: 10.1111/jth.14888. View

Stein P, Beemath A, Olson R . Obesity as a risk factor in venous thromboembolism. Am J Med. 2005; 118(9):978-80. DOI: 10.1016/j.amjmed.2005.03.012. View

Klok F, Kruip M, van der Meer N, Arbous M, Gommers D, Kant K . Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191:145-147. PMC: 7146714. DOI: 10.1016/j.thromres.2020.04.013. View

10.

Bikdeli B, Madhavan M, Jimenez D, Chuich T, Dreyfus I, Driggin E . COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020; 75(23):2950-2973. PMC: 7164881. DOI: 10.1016/j.jacc.2020.04.031. View

11.

Stein P, Goldman J, Matta F, Yaekoub A . Diabetes mellitus and risk of venous thromboembolism. Am J Med Sci. 2009; 337(4):259-64. DOI: 10.1097/MAJ.0b013e31818bbb8b. View

12.

Richardson S, Hirsch J, Narasimhan M, Crawford J, McGinn T, Davidson K . Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20):2052-2059. PMC: 7177629. DOI: 10.1001/jama.2020.6775. View

13.

Barrett C, Moore H, Yaffe M, Moore E . ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A comment. J Thromb Haemost. 2020; 18(8):2060-2063. PMC: 9770921. DOI: 10.1111/jth.14860. View

14.

Llitjos J, Leclerc M, Chochois C, Monsallier J, Ramakers M, Auvray M . High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020; 18(7):1743-1746. PMC: 7264774. DOI: 10.1111/jth.14869. View

15.

Lu H, Stratton C, Tang Y . Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020; 92(4):401-402. PMC: 7166628. DOI: 10.1002/jmv.25678. View